A LAMP-based assay for the molecular detection of group B Streptococcus.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 14 06 2023
accepted: 07 08 2023
medline: 25 9 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: ppublish

Résumé

Streptococcus agalactiae remains a major pathogen in human health, especially in neonatal infection. Detection in pregnant women is essential to initiate intrapartum antibiotic prophylaxis. This study compared the HiberGene loop-mediated isothermal amplification (LAMP) assay to culture, the reference method, for the detection of group B Streptococcus (GBS) in pregnant women. This was a prospective multicenter study conducted in four French hospitals. Three hundred fifty-four non-redundant routine care vaginal swabs were analyzed by both methods, LAMP assay and culture. Clinicians and patients were blinded to the results of the LAMP assay. Three hundred thirty-seven samples presented concordant results, 15 presented discordant results, and 2 were invalid using the LAMP assay (excluded from the study). Compared to culture, the LAMP assay had a sensitivity of 87.7%, a specificity of 98%, a negative predictive value of 97.6%, and a positive predictive value of 89.3%. The HiberGene GBS LAMP assay is an easy test that possesses good performances compared with the reference method, culture. It could be used in case of emergency when a quick result is needed.

Identifiants

pubmed: 37702956
doi: 10.1007/s10096-023-04656-z
pii: 10.1007/s10096-023-04656-z
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1245-1250

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K et al (2009) Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis 49:85–92. https://doi.org/10.1086/599369
doi: 10.1086/599369 pubmed: 19480572
Verani JR, Schrag SJ (2010) Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 37:375–392. https://doi.org/10.1016/j.clp.2010.02.002
doi: 10.1016/j.clp.2010.02.002 pubmed: 20569813
Joubrel C, Tazi A, Six A, Dmytruk N, Touak G, Bidet P et al (2015) Group B Streptococcus neonatal invasive infections, France 2007–2012. Clin Microbiol Infect 21:910–916. https://doi.org/10.1016/j.cmi.2015.05.039
doi: 10.1016/j.cmi.2015.05.039 pubmed: 26055414
Van der Mee-Marquet N, Fourny L, Arnault L, Domelier A-S, Salloum M, Lartigue M-F et al (2008) Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites. J Clin Microbiol 46:2906–2911. https://doi.org/10.1128/JCM.00421-08
doi: 10.1128/JCM.00421-08 pubmed: 18632904 pmcid: 2546740
Hays C, Touak G, Bouaboud A, Fouet A, Guignot J, Poyart C, et al. Perinatal hormones favor CC17 group B Streptococcus intestinal translocation through M cells and hypervirulence in neonates. ELife (n.d.) 8:e48772. https://doi.org/10.7554/eLife.48772 .
Hughes RG, Brocklehurst P, Steer PJ, Heath P, Stenson BM on behalf of the Royal College of Obstetricians and Gynaecologists (2017) Prevention of early-onset neonatal group B streptococcal disease. Green-top Guideline No. 36. BJOG 124:e280–e305. https://doi.org/10.1111/1471-0528.14821
Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. 1996. MMWR Recomm Rep (n.d) 45:1–24
ANAES. Antenatal prevention of the risk of early neonatal bacterial infection. Guidelines. September 2001. (n.d)
Tazi A, Réglier-Poupet H, Dautezac F, Raymond J, Poyart C (2008) Comparative evaluation of Strepto B ID chromogenic medium and Granada media for the detection of group B Streptococcus from vaginal samples of pregnant women. J Microbiol Methods 73:263–265. https://doi.org/10.1016/j.mimet.2008.02.024
doi: 10.1016/j.mimet.2008.02.024 pubmed: 18448181
de-Paris F, Pinheiro Machado ABM, Gheno TC, Ascoli BM, de Oliveira KRP, Barth AL (2011) Group B Streptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. Braz J Infect Dis 15:323–7. https://doi.org/10.1016/S1413-8670(11)70199-4
doi: 10.1016/S1413-8670(11)70199-4 pubmed: 21861001
Parida M, Sannarangaiah S, Dash PK, Rao PVL, Morita K (2008) Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev Med Virol 18:407–421. https://doi.org/10.1002/rmv.593
doi: 10.1002/rmv.593 pubmed: 18716992 pmcid: 7169140
Dingle TC, Butler-Wu SM (2013) Maldi-tof mass spectrometry for microorganism identification. Clin Lab Med 33:589–609. https://doi.org/10.1016/j.cll.2013.03.001
doi: 10.1016/j.cll.2013.03.001 pubmed: 23931840
Curry A, Bookless G, Donaldson K, Knowles SJ (2018) Evaluation of hibergene loop-mediated isothermal amplification assay for detection of group B Streptococcus in recto-vaginal swabs: a prospective diagnostic accuracy study. Clin Microbiol Infect 24:1066–1069. https://doi.org/10.1016/j.cmi.2018.01.008
doi: 10.1016/j.cmi.2018.01.008 pubmed: 29409961
Tittel-Elmer M, de Tejada BM, Renzi G, Schrenzel J (2023) Performance of the HiberGene Group B Streptococcus kit, a loop-mediated isothermal amplification-based assay for GBS screening during pregnancy. Eur J Clin Microbiol Infect Dis 42:217–219. https://doi.org/10.1007/s10096-022-04534-0
doi: 10.1007/s10096-022-04534-0 pubmed: 36449147
Gao K, Deng Q, Huang L, Chang C-Y, Zhong H, Xie Y et al (2021) Diagnostic performance of various methodologies for group B Streptococcus screening in pregnant woman in China. Front Cell Infect Microbiol 11:651968. https://doi.org/10.3389/fcimb.2021.651968
doi: 10.3389/fcimb.2021.651968 pubmed: 34109134 pmcid: 8183470
Guidelines for the detection and identification of group B Streptococcus. ASMOrg n.d. https://asm.org/Guideline/Guidelines-for-the-Detection-and-Identification-of . Accessed 26 Sep 2022
Group B Strep Prevention Guidelines | CDC 2022. https://www.cdc.gov/groupbstrep/guidelines/index.html (accessed April 3, 2023).
El Helali N, Habibi F, Azria E, Giovangrandi Y, Autret F, Durand-Zaleski I et al (2019) Point-of-care intrapartum group B Streptococcus molecular screening: effectiveness and costs. Obstet Gynecol 133:276–281. https://doi.org/10.1097/AOG.0000000000003057
doi: 10.1097/AOG.0000000000003057 pubmed: 30633130

Auteurs

Coralie Lemaire (C)

Service de Bactériologie-Virologie, CHRU de Tours, Université de Tours, 37044, Tours, France.

Mélinda Cheminet (M)

Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Service de Bactériologie, Université Paris Cité, 75014, Paris, France.

Claire Duployez (C)

Laboratoire de Bactériologie, CHU de Lille, Université de Lille, 59000, Lille, France.

Mathilde Artus (M)

Laboratoire de Biologie Médicale, CH de Quimper, 29000, Quimper, France.

Yassine Ballaa (Y)

Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Service de Bactériologie, Université Paris Cité, 75014, Paris, France.

Laura Devos (L)

Laboratoire de Bactériologie, CHU de Lille, Université de Lille, 59000, Lille, France.

Céline Plainvert (C)

Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Service de Bactériologie, Université Paris Cité, 75014, Paris, France.
Centre National de Référence Des Streptocoques, Hôpital Cochin, 75014, Paris, France.

Claire Poyart (C)

Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Service de Bactériologie, Université Paris Cité, 75014, Paris, France.
Centre National de Référence Des Streptocoques, Hôpital Cochin, 75014, Paris, France.

Florence Le Gall (F)

Laboratoire de Biologie Médicale, CH de Quimper, 29000, Quimper, France.

Asmaa Tazi (A)

Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Service de Bactériologie, Université Paris Cité, 75014, Paris, France.
Centre National de Référence Des Streptocoques, Hôpital Cochin, 75014, Paris, France.

Philippe Lanotte (P)

Service de Bactériologie-Virologie, CHRU de Tours, Université de Tours, 37044, Tours, France. philippe.lanotte@univ-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH